Want to be on the cutting edge of disease treatment? Learn how companies like Immunyx Pharma are on the front lines in the battle against unknown diseases with the JLABS/BARDA Blue Knight program. Seth Salpeter, Co-Founder and CEO of Immunyx Pharma guests on BioTalk with Rich Bendis
Lily Qi, Maryland State Delegate
Reverse BioTalk – Jeff Galvin, CEO of American Gene Technologies Interviews Rich Bendis, CEO and President of BioHealth Innovation, Inc.
Paul Rennie, OBE and Professor Jason Snape (EP.92)
Jeff Boyle, Ellume USA (EP.91)
Howard Carolan, CEO of CoapTech, and Neil Davis, Program Director at University of Maryland Baltimore (UMB) (EP.90)
Murat Kalayoglu, MD, PhD - Cartesian Therapeutics (EP.89)
Dr. Laurie E. Locascio, University of Maryland (EP.88)
Julie Lenzer, University of Maryland (EP.87)
Dr. Anne Khademian, Universities at Shady Grove (USG)
Eric Richman, Gain Therapeutics (EP.85)
Marina Massingham, Aifred Health, and Laurent Waessa, Québec Government Office (EP.84)
Dr. Dipanjan Pan and Phil Robilotto, University of Maryland (EP.83)
Conley Jones, Alexandria Venture Investments (EP.82)
John Mumm, Deka BioSciences (EP.81)
Troy A LeMaile-Stovall, TEDCO (EP.80)
Brett Malone, Virginia Tech Research Center (EP.79)
New “Virginia Bio-Connect” Statewide Consortium and Scale-Up Initiative (EP.78)
Ron Piervincenzi, Ph.D., USP (EP.77)
Chris Mathia, Innara Health, and Keith Molzer, Flyover Capital (EP.76)
Dr. James Crowe Jr. MD, Vanderbilt Vaccine Center (EP.75)
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money